| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.829 | 42.707 | 48.565 | 48.284 | 43.279 | 9.528 | 13.328 | 9.595 | 3.903 | 0 |
| Total Income - EUR | 4.829 | 42.707 | 48.565 | 50.669 | 43.281 | 15.265 | 17.533 | 20.469 | 3.903 | 0 |
| Total Expenses - EUR | 3.240 | 23.130 | 32.543 | 46.734 | 26.364 | 16.764 | 14.217 | 17.602 | 11.550 | 3.690 |
| Gross Profit/Loss - EUR | 1.589 | 19.577 | 16.021 | 3.934 | 16.917 | -1.499 | 3.316 | 2.867 | -7.647 | -3.690 |
| Net Profit/Loss - EUR | 1.444 | 18.818 | 15.536 | 3.451 | 16.484 | -1.594 | 3.186 | 2.761 | -7.686 | -3.690 |
| Employees | 2 | 5 | 5 | 2 | 2 | 2 | 3 | 1 | 1 | 0 |
Check the financial reports for the company - Mateo Med 09 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.300 | 7.278 | 7.237 |
| Current Assets | 2.060 | 23.794 | 38.350 | 23.307 | 38.110 | 35.723 | 29.021 | 16.360 | 4.358 | 1.743 |
| Inventories | 0 | 3.423 | 3.704 | 1.640 | 2.192 | 1.280 | 209 | 714 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 2.060 | 20.371 | 34.646 | 21.667 | 35.918 | 34.443 | 28.812 | 15.646 | 4.358 | 1.743 |
| Shareholders Funds | 1.911 | 20.710 | 35.896 | 18.330 | 34.470 | 32.222 | 24.054 | 16.217 | 8.482 | 4.745 |
| Social Capital | 45 | 45 | 44 | 43 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 149 | 3.084 | 2.454 | 4.977 | 3.640 | 3.501 | 4.967 | 7.443 | 3.155 | 4.235 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9329 - 9329" | |||||||||
| CAEN Financial Year |
9329
|
|||||||||
Comments - Mateo Med 09 Srl